Hyperbaric oxygen therapy is a Medicare-approved emergency treatment for cyanide poisoning
Hyperbaric oxygen therapy is a Medicare-approved emergency treatment for cyanide poisoning
Understanding cyanide poisoning and how HBOT restores cellular oxygen utilization
Cyanide poisoning is a rapidly fatal medical emergency caused by exposure to hydrogen cyanide gas, cyanide salts or cyanogenic compounds. Sources of cyanide exposure include house fire smoke (burning synthetic materials produce hydrogen cyanide), industrial accidents in mining, electroplating and chemical manufacturing, and intentional poisoning. Cyanide is also a product of combustion in many fires, meaning smoke inhalation victims frequently sustain combined cyanide and carbon monoxide poisoning.
Cyanide kills through a unique and rapidly lethal mechanism: it binds with extremely high affinity to cytochrome c oxidase — the terminal enzyme of the mitochondrial electron transport chain that converts oxygen into ATP. By blocking this enzyme, cyanide causes cellular energy failure throughout the entire body simultaneously, even when blood oxygen levels are completely normal. The cells receive oxygen but cannot use it. The clinical result is rapid loss of consciousness, seizures, cardiovascular collapse and brain death — all within minutes of significant exposure.
The diagnosis of cyanide poisoning is often clinical rather than laboratory-based in the acute setting, because serum cyanide levels take too long to return to guide management. The classic presentation of cyanide toxicity includes altered consciousness, cardiovascular instability, lactic acidosis (from anaerobic metabolism) and cherry-red skin (from venous blood remaining oxygenated because cells cannot use it). In fire victims, cyanide poisoning should always be suspected alongside carbon monoxide poisoning.
HBOT addresses cyanide poisoning through a fundamentally different mechanism than antidotes: it raises dissolved plasma oxygen to concentrations that directly outcompete cyanide for binding to cytochrome c oxidase, restoring cellular respiration throughout the body’s tissues. This mechanism is well-established and has earned HBOT its status as a Medicare-approved indication for cyanide poisoning.
Rapid loss of consciousness or altered mental status
Severe lactic acidosis (elevated blood lactate from anaerobic metabolism)
Cardiovascular instability, hypotension and cardiac arrhythmias
Seizures from cerebral energy failure
Cherry-red skin or mucous membranes (venous blood remains oxygenated)
Persistent neurological deficits and cognitive impairment in survivors without adequate treatment
How HBOT reverses cyanide poisoning at the cellular level
Cyanide’s lethal mechanism — binding of cytochrome c oxidase — is directly addressed by HBOT’s ability to deliver dissolved oxygen to tissue at concentrations that displace the toxin from its target.
Outcompetes cyanide for cytochrome c oxidase at the cellular level
Restores brain and cardiac oxygen delivery immediately
Treats concurrent carbon monoxide poisoning from smoke inhalation
Reduces neurological sequelae and cognitive damage
Accelerates cyanide metabolism and clearance
Synergizes with antidote therapy
For Providers
Evidence for HBOT in cyanide poisoning
HBOT for cyanide poisoning has a well-established mechanistic basis and is supported by clinical case series, animal studies and the strong parallel with CO poisoning where HBOT has definitive RCT evidence.
Mechanistic foundation — cytochrome c oxidase competition: The mechanism by which HBOT reverses cyanide poisoning is well-characterized: dissolved plasma oxygen at hyperbaric pressures reaches tissue concentrations that compete with cyanide for the Fe3+ site of cytochrome c oxidase. The competition is concentration-dependent, meaning higher oxygen concentrations more effectively displace cyanide. At 2.5 to 3.0 ATA, dissolved oxygen concentrations are sufficient to restore enzyme function even in the presence of cyanide. [Isom GE, Borowitz JL. Annu Rev Pharmacol Toxicol. 1995;35:129–144. PMID: 7598493]
Parallel with CO poisoning — shared HBOT mechanism: The most definitive HBOT evidence in toxic exposures comes from carbon monoxide poisoning, where Weaver et al.’s landmark randomized controlled trial in the New England Journal of Medicine demonstrated that HBOT significantly reduces the rate of cognitive sequelae compared to normobaric oxygen. Given that cyanide poisoning frequently co-occurs with CO poisoning in fire victims, and that HBOT addresses both toxins’ mechanisms simultaneously, the HBOT evidence base for CO is directly applicable to combined poisoning scenarios. [Weaver LK et al. N Engl J Med. 2002;347(14):1057–1067. PMID: 12362009]
Combined CO/cyanide poisoning in fire victims: Studies of house fire victims have demonstrated that cyanide and CO co-poisoning is the rule rather than the exception when synthetic materials are involved. A study by Baud et al. found elevated cyanide levels in a substantial proportion of fire victims presenting with altered consciousness, and documented that cyanide toxicity significantly contributed to mortality independently of CO poisoning. HBOT’s dual mechanism — addressing both CO and cyanide — makes it particularly valuable in this common presentation. [Baud FJ et al. N Engl J Med. 1991;325(25):1761–1766. PMID: 1944484]
Clinical case series and guidelines: Multiple published case reports and series document survival and neurological recovery in cyanide poisoning patients treated with HBOT, including cases where antidote therapy alone had failed to produce clinical improvement. The Undersea and Hyperbaric Medical Society (UHMS) endorses HBOT for cyanide poisoning, and the condition is recognized in emergency medicine guidelines as a HBOT indication. [UHMS Hyperbaric Oxygen Therapy Indications, 14th Edition, 2019]
Emergency HBOT protocol for cyanide poisoning at Bay Area Hyperbarics
In cyanide poisoning, time to HBOT is the most critical variable. Every minute of continued cellular hypoxia causes further irreversible neurological damage. We treat cyanide poisoning with the same urgency as carbon monoxide poisoning — as a true emergency requiring immediate intervention.
Emergency triage and antidote coordination
Cyanide poisoning is a medical emergency. Simultaneously with HBOT initiation, our team coordinates with emergency medicine to ensure hydroxocobalamin (Cyanokit) and/or sodium thiosulfate have been administered. We triage urgently to compress the time between exposure and HBOT initiation, as outcomes deteriorate with delay.
High-pressure oxygen treatment at 2.5 to 3.0 ATA
The patient breathes 100% oxygen at 2.5 to 3.0 atmospheres absolute — the highest standard HBOT pressures — for 90 minutes per session. In severe cyanide poisoning with neurological involvement, multiple sessions over the first 24 to 48 hours may be administered. The elevated pressure is essential: it generates the dissolved plasma oxygen concentrations needed to outcompete cyanide at the tissue level.
Neurological monitoring and recovery support
Following acute treatment, we monitor for neurological sequelae including cognitive effects, movement disorders and delayed neurological deficits that can emerge days after apparent recovery. Additional HBOT sessions may be recommended to minimize long-term neurological injury, coordinated with the treating neurologist.
Frequently Asked Questions
Essential information about hyperbaric oxygen therapy for cyanide poisoning.
Yes. Cyanide poisoning is one of the 16 Medicare-approved HBOT indications under the National Coverage Determination for hyperbaric oxygen therapy. Medicare and most commercial insurers cover HBOT for cyanide poisoning. Our staff coordinates authorization as part of emergency treatment initiation — insurance processing does not delay emergency care.
Cyanide or smoke inhalation exposure? Time is critical — call immediately
Bay Area Hyperbarics is equipped to treat cyanide poisoning as a medical emergency. If you or a patient has been exposed to cyanide or sustained smoke inhalation from a fire, call us immediately. Cyanide poisoning is a Medicare-approved HBOT indication — our staff coordinates authorization alongside emergency treatment.
